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Recently, heterozygous mutations in GATA6 have been found in neonatal diabetic patients with failed pancreatic 
organogenesis. To investigate the roles of GATA4 and GATA6 in mouse pancreas organogenesis, we condition-
ally inactivated these genes within the pancreas. Single inactivation of either gene did not have a major impact 
on pancreas formation, indicating functional redundancy. However, double Gata4/Gata6 mutant mice failed 
to develop pancreata, died shortly after birth, and displayed hyperglycemia. Morphological defects in Gata4/
Gata6 mutant pancreata were apparent during embryonic development, and the epithelium failed to expand as 
a result of defects in cell proliferation and differentiation. The number of multipotent pancreatic progenitors, 
including PDX1+ cells, was reduced in the Gata4/Gata6 mutant pancreatic epithelium. Remarkably, deletion of 
only 1 Gata6 allele on a Gata4 conditional knockout background severely reduced pancreatic mass. In contrast, a 
single WT allele of Gata4 in Gata6 conditional knockout mice was sufficient for normal pancreatic development, 
indicating differential contributions of GATA factors to pancreas formation. Our results place GATA factors at 
the top of the transcriptional network hierarchy controlling pancreas organogenesis.
Introduction
In vertebrates, the GATA zinc finger transcription factor family 
comprises 6 members that recognize the consensus-binding site 
A/T-GATA-A/G in the promoter regions of multiple genes (1). Stud-
ies have shown that GATA1, GATA2, and GATA3 are involved in 
hematopoietic cell differentiation, whereas GATA4, GATA5, and 
GATA6 control specification and differentiation of mesoderm- and 
endoderm-derived cell types (2, 3). In humans, GATA4 and GATA6 
mutations have been reported to cause congenital heart diseases 
(4–7), highlighting the crucial roles of these factors in embryonic 
development. More recently, genome sequencing of 27 neonatal dia-
betic patients with pancreatic agenesis or severe pancreas hypopla-
sia revealed that half of the patients had spontaneous heterozygous 
mutations in the GATA6 gene (8). These findings add GATA6 to the 
short list of genes, including PDX1 and PTF1A, identified to date 
whose inactivation causes pancreatic agenesis in humans and indi-
cates a role for GATA6 in pancreas morphogenesis.
Studies in mice have shown that GATA6 is broadly coexpressed 
with GATA4 in the early foregut endoderm and later throughout 
the nascent pancreatic epithelium (9). As embryonic development 
proceeds and pancreatic cells differentiate into endocrine and exo-
crine lineages, Gata4 and Gata6 expression become mutually exclu-
sive. Gata4 is expressed in digestive enzyme–producing acinar cells, 
whereas Gata6 expression is restricted to endocrine islets (10). The 
dynamic expression pattern of Gata4 and Gata6 during pancreatic 
development suggests a functional role for these transcription 
factors in pancreas development. Efforts to elucidate the role of 
GATA4 and GATA6 in pancreas formation have been hampered by 
the early embryonic lethality of Gata4- and Gata6-null mice. Gata4-
null mice die at E8.5, exhibiting defects in the heart tube, extraem-
bryonic endoderm, and ventral foregut morphogenesis (11, 12). 
Similarly, Gata6-null mice do not develop beyond gastrulation due 
to defects in extraembryonic tissues and die in utero (13).
Several strategies have been used to circumvent the early embry-
onic lethality of Gata4- and Gata6-null mice. By using tetraploid 
complementation approaches, it has been shown that Gata4–/– or 
Gata6–/– mutant embryos fail to induce the pancreatic developmen-
tal program (14). However, it remains unclear whether these phe-
notypes reflect a cell-autonomous role of GATA factors in pancreas 
development. In other studies, transgenic mice were engineered 
to overexpress GATA4 or GATA6 protein fused to the repressor 
domain of the Drosophila engrailed protein in the Pdx1 expression 
domain. These mice exhibited a total absence or severe reduction 
of pancreatic mass (9). Together, these studies point to an autono-
mous role of GATA factors in embryonic pancreas development.
To determine whether GATA4 and GATA6 play a functional role 
in pancreas formation, we have conditionally inactivated these 
genes in the pancreatic progenitor domain via Cre/lox technol-
ogy. While the lack of either GATA4 or GATA6 activity appears 
not to have a major impact in pancreas morphogenesis, the inacti-
vation of both Gata4 and Gata6 in the pancreatic primordia leads 
to pancreatic agenesis, indicating a functional redundancy for 
these transcription factors during pancreas formation. The pan-
creatic epithelium fails to grow, and pancreatic cell proliferation 
is reduced in Gata4/Gata6 double-mutant mice. Cell commitment 
toward endocrine and exocrine lineages is also severely impaired, 
and expression of several multipotent pancreatic progenitor 
markers, including Pdx1, is reduced in the absence of GATA4 and 
GATA6 activity. Remarkably, deletion of only 1 allele of Gata6 in a 
Gata4 conditional knockout background results in severe pancreas 
hypoplasia. In contrast, a single allele of Gata4 in the absence of 
Gata6 WT alleles is sufficient for normal pancreatic development, 
indicating that GATA4 and GATA6 are not completely equivalent 
in regulating pancreas formation. We demonstrate that GATA4 
and GATA6 transcription factors bind to 2 conserved GATA sites 
in the conserved area III of Pdx1 by ChIP and EMSA. Furthermore, 
these GATA sites are required for Pdx1 promoter activity in trans-
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genic mice. Together, our results demonstrate a crucial role for 
GATA factors in pancreas formation and identify Pdx1 as a direct 
target of GATA factors.
Results
Single inactivation of Gata4 and Gata6 does not affect pancreas formation. 
To investigate the role of GATA4 and GATA6 in pancreas develop-
ment, mice with a conditional (flox) allele of Gata4 (Gata4flox/flox) 
or Gata6 (Gata6flox/flox) were crossed to a transgenic mouse line that 
expresses Cre recombinase under the control of the pancreatic and 
duodenal homeobox gene 1 (Pdx1) promoter (Pdx1-Cre mice) (15). 
Pdx1 is expressed early in the multipotent pancreatic progenitors 
that give rise to all pancreatic cell types, thus allowing gene inacti-
vation in the entire pancreas (15). Expression analysis of Cre activ-
ity in Pdx1-Cre;Rosa26R transgenic mice revealed robust lacZ stain-
ing in the pancreatic epithelium as early as E9.5 (Supplemental 
Figure 1; supplemental material available online with this article; 
doi:10.1172/JCI63240DS1). Gata4flox/flox and Gata6flox/flox mice have 
been used previously to successfully analyze the role of these tran-
scription factors in other organs, such as heart and lung (16, 17). 
Gata4flox/flox;Pdx1-Cre and Gata6flox/flox;Pdx1-Cre mice were born at 
the expected Mendelian frequency and appeared overtly normal. 
Immunohistochemical staining demonstrated an efficient recom-
bination of Gata4 and Gata6 floxed alleles by Cre recombinase in 
pancreatic tissue (Figure 1, A–D). Gross morphological examina-
tion and histological analysis by H&E staining of newborn pancre-
ata did not reveal obvious defects in either Gata4flox/flox;Pdx1-Cre or 
Gata6flox/flox;Pdx1-Cre mice when compared with control littermates 
(Figure 1, E–J). Occasional, mild ductal dilation in acinar cells of 
Gata4flox/flox;Pdx1-Cre newborn pancreata was detected (Figure 1I). 
Figure 1
Single inactivation of Gata4 and Gata6 
does not affect pancreas formation. 
(A–D) Immunohistochemical analy-
ses show strong expression of GATA4 
in acinar cells (arrowheads in A) and 
GATA6 in endocrine cells (arrows in C) 
in pancreatic sections of control mice 
at P1. Loss of GATA4 (B, arrowheads) 
and GATA6 (D, arrows) in newborn 
conditional mutant mice is confirmed 
by immunohistochemical analysis. 
(E–G) Gross morphology of neona-
tal WT and conditional mutant guts. 
H&E-stained sections of newborn 
control (H), Gata4 (I), and Gata6 (J) 
conditional knockout pancreata does 
not reveal major defects in pancreas 
architecture. Mature acinar (amylase), 
ductal (mucin) (K–M), and islet (insu-
lin and glucagon) markers (N–P) are 
normally expressed in single Gata4 
and Gata6 conditional knockout mice. 
Insets in H–M show higher magnifica-
tion of acinar cells. Mild ductal dilation 
in acinar cells of Gata4flox/flox;Pdx1-Cre 
is observed (I and L, insets). Nuclei 
are counterstained with DAPI in K–P. 
Scale bars: 50 μm; 25 μm (insets).
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However, this phenotype was not observed in adult mice (data 
not shown), indicating a transient role for GATA4 in early exo-
crine formation. Immunohistochemical analysis for different 
epithelial cell lineages (acinar, ductal, and islet) within the pan-
creas revealed that pancreatic cell differentiation was unaffected in 
Gata4flox/flox;Pdx1-Cre and Gata6flox/flox;Pdx1-Cre mutant mice (Figure 1, 
K–P). Furthermore, Gata4flox/flox;Pdx1-Cre and Gata6flox/flox;Pdx1-Cre 
mice exhibited normal glucose tolerance to intraperitoneal glu-
cose load (Supplemental Figure 2). Taken together, our results 
show that pancreas morphogenesis is not affected by inactivation 
of either GATA4 or GATA6 alone.
Pancreatic agenesis in GATA4 and 
GATA6 double-mutant mice. Previous 
studies have shown that Gata4 and 
Gata6 have overlapping expression 
patterns at early stages of pancreas 
formation, when the pancreatic 
epithelium comprises mainly mul-
tipotent pancreatic progenitor cells 
(MPCs) (9) (see also Supplemental 
Figure 4). Since pancreas formation 
is unaffected in individual Gata4 and 
Gata6 conditional knockout mice, we 
reasoned that these transcription fac-
tors might have redundant roles dur-
ing pancreas development. To test 
this hypothesis, we generated dou-
ble Gata4flox/flox;Gata6flox/flox;Pdx1-Cre 
mutant mice (double-mutant mice 
hereafter). Double-mutant mice 
displayed growth retardation and 
hyperglycemia and died shortly 
after birth (data not shown). Dis-
section of newborn double-mutant 
mice revealed a near total absence of 
pancreatic tissue (Figure 2D). Close 
histological analysis of the pancre-
atic remnant revealed the presence 
of epithelial cysts and abundant 
stroma (Figure 2, H and Q), while 
exocrine and endocrine tissue were 
almost completely absent (Figure 2, 
L and P). Cysts comprised epithe-
lial cells that express mature ductal 
markers, including cytokeratin 19 
(Figure 2S), and react with lectin 
Dolichos biflorus agglutinin (DBA) 
(Figure 2T). Although the major-
ity of double-mutant mice displayed 
pancreatic agenesis, the degree of 
pancreatic tissue loss was variable 
among individual mutant pups, 
with approximately 20% of dou-
ble-mutant mice displaying severe 
pancreatic hypoplasia. Histological 
analysis of hypoplastic pancreata 
revealed well-differentiated tissue 
(Supplemental Figure 3). However, 
GATA4 and GATA6 expression was 
still observed in these cells, indicat-
ing inefficient excision of Gata4 and Gata6 floxed alleles, perhaps 
relating to the number of floxed alleles requiring recombination 
(Supplemental Figure 2 and data not shown). Pdx1-Cre activity in 
pancreas is reported to be mosaic (15), and thus it is conceivable that 
unrecombined Gata4+Gata6+ progenitor cells might have partially 
repopulated the pancreas in double-mutant mice. The phenotype 
of the double-mutant mice suggests that loss of both GATA4 and 
GATA6 confers a competitive disadvantage to developing pancreatic 
cells. A dramatic reduction in pancreatic mass was also observed in 
Gata4flox/flox;Gata6flox/+;Pdx1-Cre mutant mice (Figure 2, B and F), indi-
cating that pancreas formation is sensitive to reduced Gata6 dosage. 
Figure 2
Pancreatic agenesis in Gata4/Gata6 double mutant. Gross appearance of neonatal WT and conditional 
mutant guts (A–D) and pancreatic sections stained with H&E (E–H) reveal the abnormal morphology 
of double-mutant pancreata at P1. Gata4flox/flox;Gata6flox/+;Pdx1-Cre mice show pancreatic hypoplasia 
with scarcity of acinar cells (B and F). Gata4flox/+;Gata6flox/flox;Pdx1-Cre mice display normal pancre-
atic mass and architecture (C and G). Immunohistochemical analysis shows reduced expression of 
the acinar marker, amylase, in Gata4flox/flox;Gata6flox/+;Pdx1-Cre pancreatic sections (J) compared with 
Gata4flox/+;Gata6flox/flox;Pdx1-Cre (K) and control littermates (I). The double-mutant pancreatic remnant 
displays cystic structures surrounded by abundant stroma (H, L, P, and Q). The cystic structures express 
mucin (L) and cytokeratin 19 (S) and react with DBA lectin (T), which are markers of differentiated ductal 
cells. Immunostaining for E-cadherin confirms the epithelial nature of the cysts (R). Insulin and gluca-
gon staining reveals normal differentiation of the endocrine lineage in Gata4flox/flox;Gata6flox/+;Pdx1-Cre 
(N) and Gata4flox/+;Gata6flox/flox;Pdx1-Cre (O) mutant mice in comparison with control mice (M). In con-
trast, Gata4/Gata6 double-mutant mice lack endocrine cells (P). Counterstaining with DAPI was per-
formed to reveal nuclei. Scale bars: 50 μm.
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Gata4flox/flox;Gata6flox/+;Pdx1-Cre mutant mice displayed severe aci-
nar cell loss, and the architecture of remaining acini appeared 
impaired (Figure 2, F and J). Interestingly, tissue architecture of 
Gata4flox/+;Gata6flox/flox;Pdx1-Cre mutant pancreata was complete-
ly normal (Figure 2, C, G, K, and O), indicating that GATA4 and 
GATA6 are not completely equivalent in regulating pancreas forma-
tion. Together, our results indicate that pancreatic morphogenesis 
requires GATA4 and GATA6 activity and that these transcription 
factors play redundant functions in this process.
Pancreatic epithelium of Gata4/Gata6 double-mutant embryos fails to 
expand. To delineate the role of GATA4 and GATA6 during pan-
creas development, we characterized the pancreatic morphology of 
double-mutant mice at different developmental stages. During the 
early stages of pancreatic development, when bud formation occurs 
(E11.5), Gata4 and Gata6 expression completely overlapped in the 
pancreatic epithelium (Supplemental Figure 4). However, no major 
morphological changes in pancreatic epithelia of the double-mutant 
mice were observed (Supplemental Figure 4). Efficient inactivation 
of the Gata4 and Gata6 genes by Cre recombinase at this developmen-
tal stage was confirmed by immunohistochemistry (Supplemental 
Figure 4). By E13.5, the pancreatic epithelium expands and under-
goes extensive branching to form a network of tubules. Concomi-
tantly, a massive wave of endocrine and acinar cell differentiation, 
known as the secondary transition, begins (18, 19). At this embryonic 
stage, Gata6 is homogeneously expressed throughout the pancreatic 
epithelium (Supplemental Figure 4). In contrast, Gata4 displays a 
very specific expression pattern, restricted to the tips of the branch-
ing ductal epithelium, which will further adopt an acini fate (Supple-
mental Figure 4). Histological analysis of double-mutant embryos 
revealed a smaller and disorganized epithelium compared with 
Gata4flox/flox;Gata6flox/+;Pdx1-Cre, Gata4flox/+;Gata6flox/flox;Pdx1-Cre, and 
control embryos, suggesting that epithelial expansion was disrupted 
(Figure 3, A–D). Furthermore, immunohistochemical staining for 
mucin on whole-mount pancreata revealed a significant reduction in 
the pancreatic epithelial area of the double mutant when compared 
with control littermates (Supplemental Figure 5). Consistent with 
these data, pancreatic epithelial morphogenesis was severely affected 
in double-mutant embryos at E15.5 (Supplemental Figure 4). These 
results indicate that pancreatic agenesis in newborn double-mutant 
mice is a consequence of defective pancreatic morphogenesis during 
early pancreatic development.
Defects in proliferation of pancreatic progenitors in Gata4/Gata6 double-
mutant embryos. During pancreatic bud growth, extensive prolifera-
tion of the pancreatic epithelial cells occurs. To determine wheth-
er pancreatic growth arrest in double-mutant mice was due to 
defects in proliferation of pancreatic epithelial cells, we performed 
immunohistochemical analyses for proliferation markers at E13.5. 
Quantification for the mitotic marker phospho-histone H3 revealed 
a 50% reduction in proliferating cell number in the pancreatic epi-
thelium of the double-mutant embryos when compared with con-
trol, Gata4flox/flox;Gata6flox/+;Pdx1-Cre, and Gata4flox/+;Gata6flox/flox; 
Pdx1-Cre littermates (Figure 3, E–H, and M). These results were con-
Figure 3
Pancreatic epithelial expansion is 
impaired in the absence of GATA4 and 
GATA6 activity. The pancreatic epithelia 
of control, Gata4flox/flox;Gata6flox/+;Pdx1-
Cre, and Gata4flox/+;Gata6flox/flox;Pdx1-
Cre embryos at E13.5 display normal 
morphology (A–C), whereas double-
mutant pancreatic epithelium appears 
disorganized and reduced in epithelial 
area (D). Immunohistochemistry analy-
sis of the mitotic marker phospho-his-
tone H3 (PHH3) reveals a significant 
reduction in proliferating pancreatic 
epithelial cells in the double-mutant 
(H) compared with littermate embryos 
at E13.5 (E–G). Immunostaining with 
another proliferation marker, Ki67, 
confirms the reduction in proliferation 
of E13.5 pancreatic epithelial cells in 
the double mutant compared with lit-
termates (I–L). Counterstaining with 
DAPI was performed to reveal nuclei. 
Quantification of proliferating cells, 
measured as the number of PHH3 and 
Ki67-positive cells (M and N, respec-
tively) per E-cadherin–positive cells. 
*P < 0.05. Scale bars: 50 μm.
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firmed using another proliferation marker, Ki67, a protein present 
during all active phases of the cell cycle. Based on Ki67 staining, a 
high percentage of proliferative pancreatic cells was found in control, 
Gata4flox/flox;Gata6flox/+;Pdx1-Cre, and Gata4flox/+;Gata6flox/flox;Pdx1-Cre 
littermate embryos (Figure 3, I–K, and N). In contrast, double-
mutant mice showed a decreased number of Ki67-positive cells in 
the pancreatic epithelium compared with control mice (Figure 3, I, 
L, and N). Although not statistically significant, we also observed 
a decreasing trend in proliferation of pancreatic epithelial cells in 
Gata4flox/flox;Gata6flox/+;Pdx1-Cre embryos compared with control mice 
that might partially explain the hypoplastic phenotype of these mice 
at neonatal stages (Figure 3, F, J, M, and N). These results indicate 
that GATA4 and GATA6 are necessary for the normal proliferation 
rate of the pancreatic cells to sustain embryonic epithelial growth.
Endocrine and exocrine differentiation is arrested in the absence of GATA4 
and GATA6 activity. Our previous results indicated that pancreatic 
epithelial growth and expansion were impaired in the absence of 
GATA4 and GATA6 function at E13.5. The epithelial remodeling 
that occurs during this period appears to be intimately connected 
to the formation of different progenitor domains in the progenitor 
ductal epithelium. Different pancreatic lineage progenitors display 
a characteristic distribution within the pancreatic epithelium at this 
embryonic stage (20). Multipotent progenitor cells are found at the 
tips of the branching pancreatic epithelium, while ductal-endocrine 
progenitor cells are located along the trunk (20–22). The tip and 
trunk domains can be easily identified by the expression of Carboxy-
peptidase A1 (Cpa1) and Neurogenin 3 (Ngn3), respectively (20, 23). 
Cpa1 and Ngn3 expression were ana-
lyzed by immunohistochemistry to 
determine whether the establish-
ment of different pancreatic cell lin-
eages within MPCs was affected in 
double-mutant mice. As expected, 
cells stained for Cpa1 were observed 
at the tips of the pancreatic epithe-
lium, and Ngn3+ cells were located 
in the epithelial trunk in control, 
Gat a4 f lox/f lox;Gat a6 f lox/+;Pdx1-Cre , 
and Gata4flox/+;Gata6flox/flox;Pdx1-Cre 
embryos (Figure 4, A–C, and E–G). In 
stark contrast, the pancreatic epithe-
lium of the double-mutant embryos 
lacked clear tip-trunk structures, and 
Cpa1+ cells were totally absent in 
Gata4/Gata6 mutant pancreatic epi-
thelium (Figure 4D). Indeed, no clear 
acinar morphology could be observed 
in double-mutant pancreas by H&E 
staining (Figure 3D). Endocrine 
commitment was affected as well in 
double-mutant embryos, as only a 
low number of Ngn3-expressing cells 
were found in the epithelial trunk 
(Figure 4H). In concordance with 
this observation, the number of cells 
expressing the transcription factor 
Nkx2.2, an endocrine progenitor 
marker regulated by Ngn3 (24), was 
also dramatically decreased in the 
double-mutant pancreata compared 
with littermate embryos (Figure 4, I and L). Thus, differentiation 
of pancreatic multipotent progenitor cells toward acinar and endo-
crine lineages requires GATA4 and GATA6 function.
GATA4 and GATA6 are required to maintain the pancreatic progenitor 
cell pool. Exocrine and endocrine progenitors failed to form properly 
in Gata4/Gata6 mutant mice, raising the question of whether MPC 
formation and/or identity might be affected as well. To test this 
hypothesis, we decided to analyze the expression of several transcrip-
tion factors that define MPC identity, including Pdx1, Ptf1a, Sox9, 
and Nkx6.1, in double-mutant embryos at E13.5 (22, 23, 25, 26). 
MPCs of control and Gata4flox/+;Gata6flox/flox;Pdx1-Cre mice displayed 
normal distribution and expression levels of progenitor markers 
(Figure 5, A, C, E, G, I, K, M, and O). In contrast, the numbers of 
Pdx1-, Ptf1a-, Sox9-, and Nkx6.1-expressing cells in double-mutant 
embryos were dramatically reduced compared with control and 
Gata4flox/+;Gata6flox/flox;Pdx1-Cre littermate embryos (Figure 5, D, H, 
L, and P). The decrease of Pdx1- and Ptf1a-expressing cells was par-
ticularly remarkable, as only a few positive cells could be observed in 
the epithelium of the double-mutant embryos (Figure 5, D and H). 
The reduced pool of cells expressing MPC markers in double-mutant 
embryos led to an overall decrease in the expression of progenitor 
markers (Figure 5Q). A decrease in the number of cells expressing Pdx1, 
Ptf1a, and Nkx6.1 was also found in Gata4flox/flox;Gata6flox/+;Pdx1-Cre, 
consistent with these mice displaying defects in pancreas formation 
at birth (Figure 5, B, F, J, and N). These results indicate that GATA4 
and GATA6 activity are required to maintain normal numbers of 
MPCs during pancreatic development.
Figure 4
Endocrine and acinar differentiation are compromised in Gata4/Gata6 double-mutant embryos. 
The enzyme Carboxipeptidase A1 (Cpa1) is expressed in the multipotent progenitor cell popula-
tion located at the tip of the E13.5 branching epithelium in control, Gata4flox/flox;Gata6flox/+;Pdx1-Cre, 
and Gata4flox/+;Gata6flox/flox;Pdx1-Cre mice (A–C, arrowheads). In stark contrast, Cpa1+ cells were not 
detected in the double-mutant pancreatic epithelium (D). The proendocrine markers Ngn3 (E–G) and 
Nk2.2 (I–K) were mainly expressed in the epithelial trunk of control, Gata4flox/flox;Gata6flox/+;Pdx1-Cre, 
and Gata4flox/+;Gata6flox/flox;Pdx1-Cre embryos at E13.5. On the contrary, endocrine differentiation is 
disrupted in the double-mutant embryos as the number of cells expressing Ngn3 (H) and Nkx2.2 (L) 
are reduced compared with littermate embryos. The pancreatic epithelium is outlined in white in H and 
L. Counterstaining with DAPI was performed to reveal nuclei. Scale bars: 50 μm.
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GATA4 and GATA6 bind to 2 conserved GATA sites in the Pdx1 promot-
er region. The impairment in pancreatic epithelial growth and cell 
differentiation observed in Gata4/Gata6 mutant mice is reminis-
cent of that in Pdx1- and Ptf1a-null mice (25, 27). This observation, 
in combination with the dramatic reduction in the number of 
cells expressing both Pdx1 and Ptf1a in the absence of GATA4 and 
GATA6 activity, prompted us to investigate whether GATA factors 
might regulate Ptf1a and Pdx1 expression in pancreatic progeni-
tors. Previous studies have identified a 5′ distal enhancer region 
that controls the expression of Ptf1a in both dorsal and ventral 
pancreatic buds as early as E10.5 (28). Our bioinformatics analyses 
did not identify any conserved GATA site within these regulatory 
sequences, suggesting that the activity of this enhancer during 
pancreatic development might be independent of GATA factors. 
In spite of this, we cannot discard a role for GATA factors in the 
transcriptional regulation of Ptf1a through different regulatory 
sequences. Indeed, the relatively nonconserved proximal promoter 
contains several GATA sites that were able to bind recombinant 
GATA4 and GATA6 proteins (Supplemental Figure 6). However, 
this region has only so far been associated with the transcriptional 
control of Ptf1a at later stages of pancreas development (28).
The transcriptional regulation of Pdx1 has been extensively stud-
ied, and several regulatory sequences or enhancers in the 5′ conserved 
region of the Pdx1 promoter have been identified (29, 30). These 
enhancers, known as areas I, II, III, and IV, are bound by transcription 
factors, including HNF1a, Foxa2, Foxa1, HNF6, Pax6, MafA, and 
Ptf1, to direct Pdx1 expression in pancreatic progenitors and/or in 
adult β cells (29, 31–37). Areas I and II direct Pdx1 expression in pan-
creatic endocrine cells, but not exocrine cells, whereas the conserved 
area III controls the expression of Pdx1 in pancreatic progenitor cells 
(37). With this consideration, we analyzed the conserved enhancer 
areas in the Pdx1 locus for candidate GATA sites. Interestingly, 2 
perfect and conserved candidate GATA-binding sites were found 
in area III of the previously identified Pdx1 enhancer (Figure 6A). 
To determine whether these 2 putative sites, called G1 and G2, 
represent bona fide sites for GATA factors in the Pdx1 enhancer, 
Figure 5
Reduced number of MPCs in Gata4/
Gata6 double-mutant mice. Con-
trol embryos show strong expres-
sion of all multipotent pancreatic 
progenitor markers, Pdx1, Ptf1a, 
Sox9, and Nkx6.1 at E13.5 (A, E, 
I, and M, respectively). Similarly, 
Gata4flox/+;Gata6flox/flox;Pdx1-Cre 
embryos display normal distribu-
tion and expression levels (C, G, 
K, and O). However, Gata4flox/flox; 
Gata6flox/+;Pdx1-Cre mice show a 
significant decrease of cell numbers 
expressing Pdx1, Ptf1, and Nkx6.1 
(B, F, and N) and a moderate reduc-
tion in the number of Sox9+ cells 
(J). The reduced number of cells 
expressing all pancreatic progenitor 
markers is even more dramatic in the 
double mutant (D, H, L, and P). (Q) 
qPCR analysis of multipotent pancre-
atic progenitor markers in E13.5 pan-
creata. *P < 0.02; **P < 0.001. Scale 
bars: 50 μm.
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we assessed GATA4 and GATA6 protein binding (Figure 6B). 
First, we performed EMSA using recombinant proteins. Recombi-
nant GATA4 protein bound efficiently to labeled oligos encompass-
ing the Pdx1 G1 and Pdx1 G2 GATA sites (Figure 6B, lanes 2 and 
8). The binding to G1 and G2 sites was specific. as it was competed 
off by excess, unlabeled self probe (Figure 6B, lanes 3 and 9) and by 
excess, unlabeled GATA control probe (Figure 6B, lanes 4 and 10). 
In contrast, binding of GATA4 to G1 and G2 sites was not competed 
off by unlabeled mutant versions of the G1 and G2 sites, G1m and 
G2m (Figure 6, A and B, lanes 5 and 11), or GATA mutant control 
site (Figure 6B, lanes 6 and 12). Similarly to GATA4, recombinant 
GATA6 protein strongly bound to both G1 and G2 sites of the Pdx1 
enhancer (Figure 6B, lanes 14 and 20). This binding was specific, as 
it was competed off by an excess of unlabeled self probe (Figure 6B, 
lanes 15 and 21), but not by an excess of unlabeled mutant probes 
(Figure 6B, lanes 17 and 23). In addition, we found 2 conserved 
GATA sites in conserved area I that were able to bind GATA4 and 
GATA6 in EMSA experiments (Supplemental Figure 7), suggesting 
Figure 6
GATA4 and GATA6 bind to the Pdx1 conserved area III in vitro and in pancreatic cell line. (A) Highly conserved region in the cis-regulatory area III 
of Pdx1. Two conserved GATA sites, as revealed by bioinformatics analysis, are shown in blue boxes. Numbers indicate the position of the GATA 
sites relative to the Pdx1 translational start site. Point mutations introduced into GATA sites, G1m and G2m, are indicated in red lowercase. Aster-
isks denote nucleotides that have been perfectly conserved between mouse and human. (B) Recombinant GATA4 and GATA6 proteins are able to 
bind to G1 and G2 GATA sites of the Pdx1 enhancer as shown by EMSA. Competition experiments were performed by adding excess unlabeled 
probes of G1, G2, or control (denoted as c in competitor row) GATA sites, and the corresponding mutant versions (G1m, G2m, or cm) to the bind-
ing reaction. (C) ChIP experiments performed in mouse pancreatic ductal cells (mPAC cells) using specific GATA4 and GATA6 antibodies (lanes 
2, 3, respectively) and nonspecific anti-IgG (lane 4) show that anti-GATA4 and anti-GATA6 antibodies are able to immunoprecipitate the GATA 
sites of the Pdx1 conserved area III, but not nonspecific genomic regions. Lane 1 contains PCR products from input DNA (Inp) amplified prior to 
immunoprecipitation. Sizes of the PCR products in bp are shown on the right. (D) A WT Pdx1 promoter-luciferase construct (pGL3-Pdx1-WT) is 
significantly activated by endogenous factors present in mPAC cells compared with the activity of the empty reporter pGL3 vector. Mutations in 
the GATA sites of Pdx1 (pGL3-Pdx1-mut) significantly attenuate the luciferase activity. *P = 0.002; **P = 0.005.
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that other GATA sites may also participate in the transcriptional 
regulation of Pdx1 at later stages of pancreas development.
To investigate whether GATA4 and GATA6 could bind to con-
served area III of the Pdx1 cis-regulatory sequences in pancreatic 
cells, we performed a ChIP assay in a murine pancreatic ductal cell 
line, mPAC, that endogenously expresses GATA4, GATA6, and 
PDX1 (data not shown). Anti-GATA4 antibody was able to specifi-
cally immunoprecipitate DNA fragments encompassing the G1 and 
G2 sites of the Pdx1 conserved area III, but not nonspecific genomic 
regions (Figure 6C, lane 2). Incubation of sheared DNA with anti-
GATA6 also resulted in specific immunoprecipitation of DNA frag-
ments containing the GATA sites of the Pdx1 enhancer (Figure 6C, 
lane 3). The addition of nonspecific IgG to the reaction did not 
result in the immunoprecipitation of the Pdx1 conserved area III 
or nonspecific genomic regions (Figure 6C, lane 4), confirming the 
specificity of the immunoprecipitation by the corresponding GATA 
antibodies. These results demonstrate that endogenous GATA4 and 
GATA6 bind to the GATA sites in the endogenous Pdx1 enhancer.
The observation that GATA4 and GATA6 bound to the Pdx1 
conserved area III by EMSA and in mPAC pancreatic cells suggests 
that GATA4 and GATA6 transcription factors are required to tran-
scriptionally regulate Pdx1 expression. Therefore, we examined the 
requirement of the G1 and G2 sites to activate the Pdx1 promoter 
in mPAC cells. A reporter construct containing the conserved area 
Figure 7
Conserved GATA sites in area III are required for Pdx1 enhancer activation in vivo. Whole-mount (A, C, E, and G) and transversal sections (B, 
D, F, and H) of representative Pdx1-WT-lacZ and Pdx1-mut-lacZ transgenic embryos stained with X-gal. β-gal activity in both dorsal and ventral 
pancreatic buds is first observed in Pdx1-WT-lacZ embryos at E9.5 (A and B). In contrast, no X-gal staining is observed in the pancreatic buds of 
Pdx1-mut-lacZ embryos (E and F, asterisk). By E10.0, β-gal activity in the Pdx1-mut-lacZ embryos (square in G, arrowhead in H) is dramatically 
reduced compared with Pdx1-WT-lacZ embryos (C and D). At E13.5, all the pancreatic epithelial cells in Pdx1-WT-lacZ embryos show homoge-
neous β-gal activity (I). Similarly, strong X-gal staining is observed in most of the pancreatic cells of Pdx1-WT-lacZ embryos at E17.5 (M). In con-
trast, lacZ expression is markedly reduced in the pancreatic epithelium of Pdx1-mut-lacZ embryos both at E13.5 (arrows in N) and at E17.5 (R). 
Immunofluorescence staining at E13.5 reveals a complete overlapping expression pattern of Pdx1 and β-gal in Pdx1-WT-lacZ pancreas (J–L), 
while only a fraction of Pdx1+ cells express β-gal in Pdx1-mut-lacZ embryos (O–Q). dp, dorsal pancreas; vp, ventral pancreas. Scale bars: 50 μm.
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III of Pdx1 was fused to the luciferase gene to generate the pGL3-
Pdx1-WT reporter plasmid. Likewise, the 2 conserved GATA sites 
were mutated to generate the pGL3-Pdx1-mut reporter plasmid. 
The luciferase activity of these plasmids was measured in transient-
ly transfected mPAC cells. mPAC cells transfected with pGL3-Pdx1-
WT display significantly higher luciferase activity compared with 
mPAC cells transfected with the parent reporter vector pGL3-basic, 
indicating that the Pdx1 enhancer region is activated by endog-
enous factors in mPAC cells (Figure 6D). Activation of the Pdx1 
promoter significantly decreased when the 2 GATA sites in area III 
were mutated (Figure 6D). Taken together, these results demon-
strate that GATA factors are required for the transcriptional regula-
tion of Pdx1 in at least some pancreatic cell lines in vitro, suggesting 
that they may function through these sites in the MPCs.
Pdx1 transcriptional activity depends on GATA sites in vivo. Previous 
studies have reported that a region 4.6 kb upstream of the Pdx1 
translational start site containing conserved areas I, II, and III is 
sufficient to faithfully recapitulate endogenous Pdx1 expression 
throughout development in transgenic mice (38, 39). We gener-
ated transgenic mice harboring these upstream sequences of the 
Pdx1 promoter fused to the lacZ reporter gene, which we refer to 
as Pdx1-WT-lacZ. To test the requirement of the GATA sites for 
the Pdx1 enhancer activity in vivo, we introduced mutations in the 
GATA sites of Pdx1 area III to generate the Pdx1-mut-lacZ trans-
gene. The introduced mutations were identical to those used in 
EMSA analyses that abolished the binding of GATA4 and GATA6 
recombinant proteins (Figure 6, A and B). We generated 3 stable 
transgenic lines for the Pdx1-WT-lacZ construct and 2 stable trans-
genic lines for the Pdx1-mut-lacZ construct. The analysis of the 
lacZ expression by X-gal staining was performed in at least 6 trans-
genic embryos from each founder at different developmental stag-
es. We observed that the lacZ expression pattern of the transgenic 
embryos was temporally and spatially very consistent among the 
founders from each construct. As expected, the 4.6 kb cis-regula-
tory region was sufficient to recapitulate the endogenous expres-
sion of Pdx1 in transgenic embryos from early embryonic stages. 
At E9.5, β-gal activity was observed in both the dorsal and ventral 
pancreatic buds in Pdx1-WT-lacZ transgenic embryos (Figure 7, A 
and B). In contrast, no X-gal staining was observed in any Pdx1-
mut-lacZ transgenic embryo (Figure 7, E and F). By E10.0, very 
robust X-gal staining was observed in the pancreatic foregut of 
Pdx1-WT-lacZ transgenic embryos (Figure 7, C and D), while only 
a few lacZ-positive cells were detected in the pancreatic epithelium 
of Pdx1-mut-lacZ embryos (Figure 7, G and H). At midgestation, 
around E13.5, the Pdx1-WT-lacZ transgene continued to be active 
in the branching epithelial tree of the pancreas (Figure 7I). The 
β-gal expression directed by the Pdx1-WT-lacZ transgene complete-
ly mirrored the endogenous expression of Pdx1 (Figure 7, J–L). In 
sharp contrast, mutations in Pdx1 area III GATA sites resulted in 
a dramatic decrease in the Pdx1-mut-lacZ transgene activity in the 
pancreatic epithelium (Figure 7N). Immunohistochemical analy-
sis confirmed the reduction of β-gal expression in Pdx1-mut-lacZ 
embryos (Figure 7, O–Q). At later stages of development, the activ-
ity of the Pdx1-mut-lacZ transgene was even more diminished com-
pared with the activity of the Pdx1-WT-lacZ transgene (Figure 7M). 
Furthermore, X-gal staining was observed only in scattered cells 
of Pdx1-mut-lacZ pancreatic embryos (Figure 7R). These results 
indicate that GATA sites are required for Pdx1 enhancer activity 
during pancreas development and place GATA factors upstream 
of Pdx1 in the regulatory network controlling pancreas formation.
Discussion
Pancreas specification and differentiation follow a well-orchestrated 
cascade of transcription factors that control the pancreatic genetic 
program in a spatiotemporal fashion. Inactivation of several of these 
transcription factors results in pancreatic hypoplasia or pancreatic 
agenesis in humans and mice (26, 27, 40, 41), reflecting their critical 
role in pancreas formation. In the rare examples of patients with 
pancreatic agenesis in which the affected gene has been identified, 
neonatal diabetes mellitus has been associated with homozygous 
mutations in the coding region of PDX1 and PTF1A genes (42, 43).
More recently, heterozygous mutations in GATA6 have been found 
in neonatal diabetic patients associated with pancreas agenesis and 
other extrapancreatic disorders, suggesting a possible functional role 
of this gene in human pancreas formation (8). In agreement with 
these observations, our studies performed in mice have established 
the GATA family transcription factors as critical regulators of pan-
creatic development. In contrast with humans, single inactivation 
of Gata6 (or Gata4) in the mouse pancreatic progenitor cells does 
not have an obvious effect on pancreas formation. The discrepancy 
between human and mouse GATA6 function could be related to the 
previously suggested role for GATA transcription factors in earlier 
pancreas specification (9). GATA6 mutations in humans could cause 
a failure in endoderm specification toward pancreatic fate, resulting 
in pancreas agenesis. Gene inactivation by Pdx1-directed Cre expres-
sion in Gata6 mutant mice is achieved after the pancreas has been 
specified, and therefore it can be argued that a possible role for 
GATA6 (or GATA4) in pancreas specification was not addressed in 
our study. However, inactivation of Gata4 and Gata6 in the prepan-
creatic endoderm using the FoxA3-Cre line results in proper pancreat-
ic specification, suggesting that GATA factors might not be required 
to initiate the pancreatic program (44). The discrepancy between the 
mouse and human phenotype of GATA6 deficiency might also be 
explained by differences in the pancreatic genetic program between 
species. The spatiotemporal pattern of GATA factor expression dur-
ing human pancreas development has not been reported. Thus, it 
remains to be determined whether GATA4 and GATA6 expression 
overlap and are functionally redundant in early human pancreatic 
formation, as is true in the mouse.
Based on the overlapping expression of GATA4 and GATA6 in iden-
tical cell compartments of different tissues during mouse embryonic 
development and their ability to recognize the same binding sites in 
the regulatory sequences of target genes, a certain degree of functional 
redundancy between these 2 transcription factors could have been 
anticipated. For example, at the onset of cardiac development, GATA4 
and GATA6 are coexpressed, and thus, it was not entirely unexpected 
when functional studies in mice showed that GATA4 and GATA6 
had redundant roles in controlling cardiomyocyte cell differentiation 
(45). More recently, it has been reported that GATA4 and GATA6 also 
share common functions in regulating cell proliferation and differen-
tiation in proximal intestinal cells (46). Similar to these studies, our 
results indicate that these 2 GATA transcription factors are also func-
tionally complementary during early stages of pancreas formation.
The pancreatic agenesis phenotype of the Gata4/Gata6 mutant 
mice is the result of defects that occur during the early stages of 
pancreas formation. We have observed defects in pancreatic epi-
thelial morphology of double-mutant mice as early at E13.5. At 
that developmental stage, there is a marked reduction in the num-
ber of proliferating epithelial cells. Xuan et al. have reported that 
cell proliferation is decreased even at earlier embryonic stages in 
Gata4/Gata6 mutant mice, indicating that GATA4 and GATA6 
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Methods
Mice. Gata4flox/flox, Gata6flox/flox, and Pdx1-Cre mice have been previously described 
(14, 15, 23, 47). The strategy for genotyping Gata6 WT and floxed alleles has been 
previously described (47). Gata4 WT and floxed alleles were detected by PCR 
using the following primers: 5′-CCCAGTAAAGAAGTCAGCACAAGGAAAC-
3′and 5′-AGACTATTGATCCCGGAGTGAACATT-3′. Cre transgene was 
detected by PCR using the following primers: 5′-TGCCACGACCAAGTGA-
CAGC-3′ and 5′-CCAGGTTACGGATATAGTTCATG-3′.
Reporter transgenic constructs. A 4,660-bp SpeI/EcoRV fragment contain-
ing 4620 bp upstream and 40 bp downstream of the transcriptional start 
site from the mouse Pdx1 promoter region was cloned into SpeI-SmaI sites 
of the AUG–β-gal lacZ reporter plasmid (48) to generate the Pdx1-lacZ 
transgene. GATA site mutations in the Pdx1 promoter (Pdx1-mut) were 
generated by PCR using the following plus strand sequence: G1m, 
5′-CCACTAGGTAGAAGATCTGTGAGGGTCAACAC-3′; G2m, 5′-CACTC-
GCGGCCGAGGAGCTCGCATCGAGTCCCTGGC-3′. Mutagenesis was 
confirmed by sequencing on both strands.
Pdx1-WT-lacZ and Pdx1-mut-lacZ transgenic reporter fragments were 
excised from the plasmid backbone with SpeI/HindIII, gel purified, and sus-
pended in 10 mM Tris-HCl, 0.1 mM EDTA (pH 7.4), for pronuclear injection 
as described previously (49). Injected embryos were implanted into pseudo-
pregnant FVB females, and embryos were allowed to develop to adulthood 
for establishment of stable transgenic lines. Three stable transgenic lines 
harboring the Pdx1-WT-lacZ construct and 2 stable transgenic lines harbor-
ing the Pdx1-mut-lacZ construct were generated. Each transgenic line was 
bred to C57BL/6 WT mice, and the embryos or tissues from these crosses 
were stained with X-gal to visualize β-gal, as described previously (50).
Histology, immunohistochemistry, and immunofluorescence. Whole embryos 
or dissected pancreata collected at embryonic or adult stages were fixed in 
4% paraformaldehyde in PBS overnight at 4°C, dehydrated with ethanol 
and xylene, and embedded in paraffin. Sections were cut at a thickness of 
6 μm with a Leica DM6000B microtome. Sections were dewaxed through 
a series of xylene and ethanol washes. Embryos or tissues were counter-
stained with Nuclear Fast Red or H&E to visualize structures as previously 
described (49, 51). Prior to incubation with antibodies, paraffin sections 
were treated for immunohistochemistry and immunofluorescence as 
described previously (52).
The following primary antibodies were used at the indicated dilutions: 
mouse anti-GATA4 (1:100; Sc-25310, Santa Cruz Biotechnology Inc.); rabbit 
anti-GATA6 (1:50; Sc-9055, Santa Cruz Biotechnology Inc.); guinea pig anti-
Pdx1 (1:200; ab47308, Abcam); rabbit anti-Sox9 (1:800; AB5535, Millipore); 
mouse anti–E-cadherin (1:100; 610186, BD Biosciences); mouse anti-amy-
lase (1:200; Sc-46657, Santa Cruz Biotechnology Inc.); hamster anti-mucin 
(1:300; HM-1630, Thermo Scientific), rabbit anti–β-gal (1:500; 559762, MP 
Biochemicals); rabbit anti-Ki67 (1:100; RM-9106-S, Thermo Scientific); rab-
bit anti–phospho-histone H3 (1:500; 06-570, Millipore); biotinylated DBA 
(1:300; B-1035, Vector Laboratories); rabbit anti–carboxypeptidase 1 (1:800; 
1810-0006, AbD Serotec); rabbit anti-Ptf1a (1:2000; AB2153 [ref. 53], Beta 
Cell Biology Consortium), rabbit anti-glucagon (1:200; 2760, Cell Signaling), 
and mouse anti-insulin (1:500; I2018, Sigma-Aldrich). The following primary 
antibodies were obtained from the Developmental Studies Hybridoma Bank 
(DSHB) developed under the auspices of the National Institute of Child 
Health and Human Development (NICHD) and maintained by The Univer-
sity of Iowa, Department of Biology, Iowa City, Iowa, USA: mouse anti-Ngn3 
(1:200; DSHB, F25A1B3, developed by Ole D. Madsen, Hagedorn Research 
Institute, Gentofte, Denmark); rat anti–cytokeratin 19 (1:200; DSHB, 
TROMA III, developed by Rolf Kemler, Max-Planck Institute of Immunobi-
ology and Epigenetics, Freiburg, Germany); mouse anti-Nkx2.2 (1:25; DSHB, 
74.5A5, developed by Thomas M. Jessell and Susan Brenner-Morton, Colum-
bia University, New York, New York, USA); mouse anti-Nkx6.1 (1:50; DSHB, 
function is required from the early post-bud stages of pancreas 
development (44). The exact mechanism by which the loss of 
GATA4 and GATA6 results in arrested pancreatic development 
needs to be investigated. However, it is tempting to speculate that 
a critical number of pancreatic progenitors are required to ensure 
the progression of the developmental program. Thus, diminish-
ing the size of the pancreatic progenitor pool (as in Gata4/Gata6 
mutant mice) could compromise the ability to move forward in 
the organogenesis program and ultimately result in the loss of 
pancreatic mass after birth. An attractive model for the expan-
sion of MPCs would involve GATA, Pdx1, Ptf1a, and likely other 
early pancreatic transcription factors working in a cross-regulatory 
network to engage the proper level of progenitor cell proliferation 
necessary to promote the progression of pancreas organogenesis.
Although several transcription factors have been identified for 
controlling Pdx1 expression in adult β cells, less is known about 
the transcription factors that directly regulate the expression of 
Pdx1 in the early stages of pancreas development. Hnf6, Ptf1a, and 
more recently, FoxA1/FoxA2 have been identified as direct regula-
tors of early Pdx1 expression (35, 37, 41). Our in vivo transgenic 
analysis adds GATA factors to the short list of identified transcrip-
tion factors that control Pdx1 expression during early pancreatic 
development. The 2 conserved GATA sites we identified in our 
studies are located in area III of the Pdx1 regulatory sequence, an 
area that has been proposed to mediate early, pancreas-wide Pdx1 
expression (37). Consistent with this, these GATA sites are required 
for Pdx1 expression in the early pancreatic bud. Interestingly, they 
seem to be required for maintenance of Pdx1 expression at later 
stages of pancreatic formation as well. However, these mutations 
do not completely abolish Pdx1 expression, and thus it is possible 
that additional GATA sites might account for the lower β-gal activ-
ity observed in Pdx1-mut-lacZ transgenic embryos.
An interesting observation from our analyses of different combina-
tions of Gata4 and Gata6 floxed alleles is that, although both tran-
scription factors are required for proper pancreas formation, GATA4 
is more competent than GATA6 in supporting pancreas development. 
Gata4flox/+;Gata6flox/flox;Pdx1-Cre mutant pancreata appear completely 
normal. In contrast, although a pancreas is formed in Gata4flox/flox; 
Gata6flox/+;Pdx1-Cre mutant mice, a severe loss of pancreatic acinar 
mass and disrupted pancreatic morphology is observed. The more 
severe phenotype observed in Gata4flox/flox;Gata6flox/+;Pdx1-Cre embryos 
compared with the single Gata4-knockout mice suggests that GATA6 
might also contribute to exocrine development before its expression 
becomes restricted to islet and ductal cells. The partial redundancy of 
GATA4 and GATA6 indicates that they have common and distinct 
functions in regulating gene expression during pancreatic develop-
ment. It will be interesting to determine whether different DNA-bind-
ing affinities or recruitment of specific coactivators might explain the 
differences in GATA4 and GATA6 activities in pancreas development.
In summary, we have demonstrated a critical role for GATA4 and 
GATA6 transcription factors in pancreas formation. Our results 
place GATA factors at the top of the transcriptional network hier-
archy controlling pancreas organogenesis. The direct regulation 
of Pdx1 expression by GATA factors offers a model that explains 
the pathogenesis of congenital pancreatic anomalies in human. 
Advances in our current understanding of pancreatic islet forma-
tion have sparked a great interest in the development of cell-based 
therapies for diabetes. Our data here suggest that manipulation 
of GATA factor activities should be now considered when devising 
strategies to generate β cells, either in vitro or in vivo.
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Cells were harvested 48 hours after transfection, and the luciferase activity 
was measured using a Dual Luciferase Kit Assay (Promega) and detected in 
a luminometer (Glomax 20/20, Promega). At least 3 independent triplicate 
sets of transfections were performed with each construct.
Quantitative RT-PCR. Dissected pancreata from 3 E13.5 embryos of control 
(Pdx1-Cre–), Gata4flox/flox;Gata6flox/+;Pdx1-Cre, Gata4flox/+;Gata6flox/flox;Pdx1-Cre, 
and Gata4flox/flox;Gata6flox/flox;Pdx1-Cre mice were pooled to obtain RNA. 
Total RNA was isolated using RNeasy Plus Micro Kit (74034, QIAGEN), 
and cDNA was prepared using QuantiTect Reverse Transcription Kit 
(205311, QIAGEN). Quantitative PCR (qPCR) analysis was performed 
using FastStart Universal SYBR Green Master (04913850001, Roche), 
and the following primers were used: Ptf1a F, 5′-GCACTCTCTTTCCTG-
GACTGA-3′; Ptf1a R, 5′-TCCACACTTTAGCTGTACGGA-3′; Pdx1 F, 
5′-AGCTCCCTTTCCCGTGGATGAAAT-3′; Pdx1 R, 5′-TAGGCAGTAC-
GGGTCCTCTTGTTT-3′; Nkx2.2 F, 5′-TCGCTCTCCCCTTTGAACTTT-3′; 
Nkx2.2 R, 5′-GTTAACGTTGGGATGGTTTGG-3′; Sox9 F, 5′-GCAGAC-
CAGTACCCGCATCT-3′; Sox9 R, 5′-TTCAGCAGCCTCCAGAGCTT-3′; 
β-actin F, 5′-TCCTGTGGCATCCACGAAACTACA-3′; β-actin R, 
5′-ACCAGACAGCACTGTGTTGGCATA-3′. For detection of Pdx1, Ptf1, 
Sox9, and Nkx6.1, 10 ng of total cDNA was used per reaction, and each reac-
tion was done in triplicate in 3 independent experiments. Gene expression 
levels were normalized to β-actin. The gene expression changes in mutant 
mice were determined using the comparative ΔΔCt method (57).
Quantitation of proliferative cells. The number of proliferating cells were 
determined by counting phospho-histone H3– or Ki67-labeled cells with-
in the pancreatic epithelium, delimitated by E-cadherin+ cells, in a series 
of sections from at least 3 pancreatic embryos of each genotype: control, 
Gata4flox/flox;Gata6flox/+;Pdx1-Cre (4KO/6Het), Gata4flox/+;Gata6flox/flox;Pdx1-Cre 
(4Het/ 6KO), and Gata4flox/flox;Gata6flox/flox;Pdx1-Cre (4KO/6KO).
Statistics. All values are expressed as mean ± SEM. Statistical analyses were 
performed using a 2-tailed Student’s t test. P < 0.05 was considered statisti-
cally significant.
Study approval. All experiments using animals complied with institution-
al guidelines and were reviewed and approved by the Institutional Animal 
Care and Use Committee (IACUC) of the University of Sevilla, Sevilla, Spain.
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F55A10, developed by Ole D. Madsen). Rabbit, rat, guinea pig, hamster, and 
mouse Alexa Fluor 568 and Alexa Fluor 488 (Invitrogen) secondary antibod-
ies were used at 1:300 dilutions. For Nkx6.1 staining, signal from the second-
ary antibody was amplified using the TSA Fluorescein System (PerkinElmer). 
Counterstaining with DAPI was performed to visualize nuclei. The slides were 
analyzed using epifluorescence microscopy (Leica AF6000). Immunoperoxi-
dase staining for the peroxidase substrate diaminobenzidine (DAB) was per-
formed using the Vectastain Elite ABC Kit (Vector Laboratories).
EMSA. DNA-binding reactions were performed as described previously 
(54). Gata4 and Gata6 cDNAs were transcribed and translated using the 
TNT Coupled Transcription-Translation System (Promega) as described in 
the manufacturer’s directions. GATA4 and GATA6 proteins were generated 
from pCITE-GATA4 and pCITE-GATA6 plasmids, which have been described 
previously (55). The sense strand sequence of the mouse Pdx1 GATA sites 
used for EMSA were as follows: G1, 5′-GGGCCACTAGGTAGATTATCTGT-
GAGGGTCAACAC-3′; G2, 5′-GGACTCGCGGCCGAGGAGATAGCATC-
GAGTCCCTGGC-3′; G3–G4, 5′-GGGTACCTCCAGTATCAGGGAGGAC-
TATCAGGACGTCC-3′. Control and mutant control oligos for GATA sites 
have previously been described (55). The sense strand sequences for the G1 
and G2 Gata mutant sites (G1m and G2m) were the same as for the mutagen-
ic primers described above, and for G3m–G4m, the sequence was as follows: 
5′-GTACCTCCAGGATCCGGGAAGACTCTCAGGACG- 3′.
The sense strand sequences of the mouse Ptf1a GATA sites used for EMSA were 
as follows: G1, 5′-GGCATCAGGATTTTGATAAGGTTTTGAAATTTGG-3′; 
G1m, 5′-CATCAGGATTTTGCCCGGGTTTTGAAATTTGG-3′; G2–G3, 
5′-GCACTTATTTGGATAATTATATCAGCATTTAGG-3′; G2m–G3m,5′-
CACTTATTTGGTATAATCGATCAGCATTTAGG-3′.
ChIP. ChIP assays were performed using Dynabeads Protein A (100.01D, 
Invitrogen) following the recommendations of the manufacturer, with 
some modifications. Briefly, mPAC mouse pancreatic cells were grown in 
DMEM supplemented with 10% FBS on a 10-cm plate to approximately 
1.5 × 106 cells (56). At that density, cells were treated with 1% formalde-
hyde at 37°C for 10 minutes to crosslink protein-DNA complexes. Sheared 
DNA from mPAC cells was incubated with Dynabeads Protein A plus 4 μg 
of mouse anti-GATA4 antibody (Sc- 25310, Santa Cruz Biotechnology Inc.) 
or rabbit anti-GATA6 antibody (Sc-9055, Santa Cruz Biotechnology Inc.) 
for 1 hour at 4°C. The same amount of mPAC sheared DNA was incubated 
with 4 μg of nonspecific IgG as a negative control. The DNA fragments were 
collected after the incubation using a DynaMag-2 (123.21D, Invitrogen). 
Following incubation in 200 mM NaCl at 65°C overnight to reverse the 
crosslinks, the DNA was recovered by phenol-chloroform extraction and 
subjected to PCR. The following primers were used to detect the fragment 
encompassing both GATA sites of the Pdx1 promoter: 5′-TGACCAGGT-
GAAGGAAGGTCC-3′ and 5′-AGCCACCTGTGCCCGTCAAGG-3′. The 
primers used to detect the second exon of Cyclin D2 as nonspecific control 
have previously been described (54). The following primers were used to 
detect the 3′ UTR region of Pdx1 as nonspecific control II: 5′-CTTTCTG-
GATGCTGCTCACAG-3′; 5′-TAATGTAGATTTGTCTCATCC-3′.
Luciferase reporter plasmids, cell culture, and transfection. A 1,927-bp fragment 
containing 1,886 bp upstream and 41 bp downstream of the transcriptional 
start site from the mouse Pdx1 promoter region with either the WT GATA 
sequences or the GATA mutations, described above, was cloned in the pGL3-
basic reporter vector (Promega) to generate pGL3-Pdx1-WT or pGL3-Pdx1-
mut reporter plasmids. mPAC cells were maintained in DMEM supplemented 
with 10% FBS. Cells were cultured in 24-well plates at a density of 80,000 cells 
per well and transfected using Lipofectamine 2000 (Promega) following the 
manufacturer’s recommendations. Each well was transfected with 0.5 μg 
of pGL3-basic, pGL3-Pdx1-WT, or pGL3-Pdx1-mut reporter plasmids. The 
firefly luciferase activity was normalized to renilla luciferase activity by 
cotransfecting each well with 5 ng of pRL-renilla reporter vector (Promega). 
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